S2 Genomics
Latest round
- Series A
Last raised
- Jan 2024
Total raised
- $16M
Investors
- 2
About S2 Genomics
Established in 2016 and based in California, US, S2 Genomics, Inc. provides digital solutions that facilitate single-cell research with automation. As of 2023, the company is headed by its CEO Jonathan Schimmel. The company was founded by Stevan Jovanovich. The business offers an automated digital system for splitting raw tissues into individual cells or nuclei for research in cell biology and genetics. The firm product range includes Singulator 100, Singulator 200, NIC + Small Sample Cartridge, and RNase Inhibitor.
Who invested in S2 Genomics
2 investors across 1 round
See all investors in S2 Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 23, 2024
Amount
$16M
Investors
Questions about S2 Genomics
Who invested in S2 Genomics?
S2 Genomics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has S2 Genomics raised?
S2 Genomics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did S2 Genomics last raise money?
S2 Genomics's most recent round on record is a Series A, in Jan 2024.
What does S2 Genomics do?
Established in 2016 and based in California, US, S2 Genomics, Inc.
Where is S2 Genomics headquartered?
S2 Genomics is headquartered in Livermore, US.
Which VCs invest in companies like S2 Genomics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at S2 Genomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like S2 Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.